Recombinant Newcastle disease virus as a vaccine vector for cancer therapy - Wikidata - awgldk - TriplyDB

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

http://www.wikidata.org/entity/Q24602728

about

Genetically engineered Newcastle disease virus for malignant melanoma therapy Thunder and lightning: immunotherapy and oncolytic viruses collide Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells Potentiating cancer immunotherapy using an oncolytic virus Enhancement of oncolytic properties of recombinant newcastle disease virus through antagonism of cellular innate immune responses From scourge to cure: tumour-selective viral pathogenesis as a new strategy against cancer Experimental vaccines against potentially pandemic and highly pathogenic avian influenza viruses Oncolytic therapy of a recombinant Newcastle disease virus D90 strain for lung cancer.Oncolytic Immunotherapy: Conceptual Evolution, Current Strategies, and Future Perspectives Experimental infection of mice with avian paramyxovirus serotypes 1 to 9.Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.Adaptive antiviral immunity is a determinant of the therapeutic success of oncolytic virotherapy A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen.The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.Activating systemic T-cell immunity against self tumor antigens to support oncolytic virotherapy with vesicular stomatitis virus.Enhancement of the proapoptotic properties of newcastle disease virus promotes tumor remission in syngeneic murine cancer models Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma.The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma The hemagglutinin-neuramidinase protein of Newcastle disease virus upregulates expression of the TRAIL gene in murine natural killer cells through the activation of Syk and NF-κB Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model.Combined cytolytic effects of a vaccinia virus encoding a single chain trimer of MHC-I with a Tax-epitope and Tax-specific CTLs on HTLV-I-infected cells in a rat model.Newcastle disease virus: a promising agent for tumour immunotherapy.Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Evolution of oncolytic viruses: novel strategies for cancer treatment.Fighting Cancer with Mathematics and Viruses.Therapeutic potential of oncolytic Newcastle disease virus: a critical review.Recombinant Newcastle disease virus Anhinga strain (NDV/Anh-EGFP) for hepatoma therapy.Rescue of recombinant Newcastle disease virus: a short history of how it all started.Apoptin enhances the oncolytic properties of Newcastle disease virus.Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells.Construction of a minigenome rescue system for Newcastle disease virus strain Italien.Glycoprotein interactions in paramyxovirus fusion.Sharpening the Edge for Precision Cancer Immunotherapy: Targeting Tumor Antigens through Oncolytic Vaccines.Recombinant Newcastle disease virus expressing H9 HA protects chickens against heterologous avian influenza H9N2 virus challenge.Recombinant Newcastle Disease Virus Encoding IL-12 and/or IL-2 as Potential Candidate for Hepatoma Carcinoma Therapy.Oncolytic Viruses-Interaction of Virus and Tumor Cells in the Battle to Eliminate Cancer Newcastle disease virus-based H5 influenza vaccine protects chickens from lethal challenge with a highly pathogenic H5N2 avian influenza virus.Oncolytic Virotherapy and the Tumor Microenvironment.Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.

P2860

Q24597831-FC69DE5F-BA09-45C5-A94F-216FCA02A7C3 Q24597894-2D47E1B5-DDAC-44DC-8B27-BA8D9F6585E9 Q24602706-465ABB46-3B52-40B5-B711-41BDF522B639 Q24628810-2A0FB251-E175-4705-AA15-5418760F10E6 Q24631361-5524836E-3C53-4F9D-95CF-5DD095F0636C Q26822694-E339504F-DE9E-4007-974F-0DAB0F0FBB1E Q30427591-4B94E9C1-247B-44D6-A9DD-3415E83B14D7 Q33655291-0C73FA26-402D-4C5C-8D10-3B784F036AAD Q33679505-26542031-62D6-43E0-A015-F062B9CC7172 Q33828508-E123A109-2012-4E83-8047-77ECA53FF483 Q34028464-604CDD53-BAC8-40CD-B3CA-70020E2C76FB Q34057946-B40BEE02-881D-4284-8F79-3CC07A13603F Q34556927-C0A9EEA8-23FD-4EB0-B6E3-F7687FE70598 Q35112976-B443D5C3-3F9E-4C1D-9C92-2512A9D58465 Q35212733-D82C8D88-BBBB-43EE-8246-814E39A39F30 Q35575688-E60F5BEA-CB03-4A5E-89D7-755649CF7354 Q35587389-889E2D3D-BAE2-4D67-8849-C2EA7A5ABEEF Q35699080-8BB70104-F3B4-4C3A-9F94-C84FCE934102 Q36112877-5D069F0D-D244-4C52-8CC5-83D4F8AA3CCE Q36405474-27F080F4-C14A-4D2D-82F9-8E0243C117E6 Q37133496-603DBC35-E58A-4B78-AF01-02991C65BA72 Q37700567-E4170DF1-AC82-4135-BEC4-1B40FBFE1367 Q37972664-39645F26-B6A6-4FAF-AAD9-2EA91B321479 Q37990940-FB93F7D3-2C49-4F2F-8776-32A692536F14 Q38159802-6B42378E-FE46-4114-BC35-DEA7A1D975CA Q38612646-7F6A8BE9-0DBC-45F3-AF49-E1DAF28F2BEF Q38924554-D5219911-8A09-4CDC-8D80-56AEB09F4FE3 Q39131669-97936B55-8D41-40A0-93C8-7B254605E4BB Q39186172-12BC389D-60B7-481F-A9D1-461A8DDC5F7B Q39484906-17F98AF6-FE68-4A5D-9AB9-C2E30822BC06 Q39603352-AE122EAD-EE12-4EEF-BE18-00C88C517FCE Q39612067-DEF3F7C7-D1BD-4898-95BB-19D08574F632 Q39900113-6F4D45F6-674A-413E-A1BE-2A86AA8B5BA4 Q40104793-91A764E4-01D0-4598-8C4B-AF4863B018F8 Q40704109-EB07B5E1-DBB6-4710-8681-7B3C9B8EF978 Q41456207-04AE909F-20BE-431A-812E-BADFCE551E8A Q41699675-D7FA33EE-D76C-4CCE-A53A-428B466C9A9E Q47117843-3F736314-BDE4-457C-91AF-0C39E5C27D32 Q47560690-2074B3F4-F945-478A-AAF3-C610E81F5C14 Q54219825-F855AFFD-6DB4-4AC7-BC87-A6E7F39CBE62

P2860

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

http://www.wikidata.org/entity/Q24602728

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@ast

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@en

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@nl

type

label

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@ast

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@en

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@nl

prefLabel

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@ast

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@en

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@nl

P1433

Q24602728-596A89F9-90BD-4A78-ABBA-AB5AD8456AB1

P1476

Q24602728-6D318944-4C04-4A8C-B6E3-67489C76B597

P2093

Q24602728-65977703-CD21-4703-BCA8-89DD34A03E6F

Q24602728-945F88A6-1469-47F7-8978-E6385E4E69D4

P2860

Q24602728-0373F3BD-3812-4018-8103-DEF7825E4CF6

Q24602728-0443082C-9843-46CA-96FF-871872D02313

Q24602728-053B267A-3404-4D47-940E-A5F5A25E35B6

Q24602728-0BADBE9C-0234-449C-B96F-A7BB5CE85BBD

Q24602728-1E4EA7C4-7F13-43CA-A796-33A329DAF1DB

Q24602728-1E694CD4-48CF-4A7C-AD43-B435310E676D

Q24602728-1F96758C-B289-4D03-9BCA-AA28F718A704

Q24602728-290E105F-F3F5-4007-903B-0E45D3F423D0

Q24602728-2938A357-50BD-4E5A-A80E-6CC8156CB741

Q24602728-2B947536-BEAA-44C4-BE3D-0A87FC1D66E4

P304

Q24602728-8BD35AED-A447-472F-901D-696E23FBE1CD

P31

Q24602728-BC1BC596-DA70-4E1B-9B85-7CA3789FE6D5

P3181

Q24602728-D980F84C-E30A-45B4-A502-EC17C4441DE5

P356

Q24602728-FFF685C1-FF11-4E01-B5D4-3519E33B0FD2

P407

Q24602728-6026CAF8-6DFD-470D-B577-67E3F384D602

P433

Q24602728-4E959A3F-7324-4640-AEBF-A97A93E620BE

P478

Q24602728-44C99008-25D5-4D13-A2B0-71E2734D5BC5

P50

Q24602728-888333C7-E8A3-421F-80F7-82894E8C9BA6

Q24602728-987D1120-D1FB-44B2-B494-18C136B79541

P577

Q24602728-70C031AF-F8A3-4641-B139-0AD6B3F252EE

P5875

Q24602728-AF79C767-4A8D-4F08-8964-2170F12CC2D7

P698

Q24602728-EAA72E90-2672-436E-AEE7-F4E2ED32E762

P921

Q24602728-669AF75C-CDC5-43C7-8B0B-06E46023B291

Q24602728-F0752169-A631-4010-B3DE-D5DBEA164A0A

P932

Q24602728-52CD9BBF-125D-4B2E-ACD5-FDFF6D7BB55D

P3181

P356

P1433

Molecular Therapy

P1476

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

@en

P2093

Adam Vigil

http://www.w3.org/2001/XMLSchema#string

Mark A Chua

http://www.w3.org/2001/XMLSchema#string

P2860

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire

p53 mutations in human cancers

Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses.

Cancer vaccines.

Recombinant Newcastle disease virus as a vaccine vector

Natural adjuvants: endogenous activators of dendritic cells.

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus.

Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates

Protection against respiratory syncytial virus by a recombinant Newcastle disease virus vector

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

P304

1883-90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3891654

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/MT.2008.181

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Osvaldo Martinez

Adolfo García-Sastre

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23181550

http://www.w3.org/2001/XMLSchema#string

P698

18714310

http://www.w3.org/2001/XMLSchema#string

P921

vector-borne disease

P932

2878970

http://www.w3.org/2001/XMLSchema#string